Arcutis Biotherapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
![]() AMLX
Amylyx Pharmaceuticals, Inc. |
$3.92 | $120.37 M | -1.65 | 384 | $87.37 M |
![]() APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
![]() BOLT
Bolt Biotherapeutics, Inc. |
$0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
![]() CHRS
Coherus BioSciences, Inc. |
$1.62 | $193.89 M | -2.28 | 235 | $266.96 M |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
![]() DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
![]() ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
![]() ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
![]() INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
![]() MIRM
Mirum Pharmaceuticals, Inc. |
$43.09 | $1.18 B | -6.7 | 322 | $336.89 M |
![]() MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
![]() NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
![]() SPRO
Spero Therapeutics, Inc. |
$1.08 | $75.85 M | 3.19 | 46 | $96.74 M |
![]() TERN
Terns Pharmaceuticals, Inc. |
$5.71 | $462.44 M | -5.67 | 66 | $0 |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
![]() VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
![]() XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 143 | $0 |